Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
99.69 GBX | +0.19% | -3.21% | +14.59% |
04-02 | Roadside shares suspended; Adnams looks for funds | AN |
03-21 | Diaceutics upgrades diagnositc commercialisation platform, DXRX | AN |
Evolution of the average Target Price on Diaceutics PLC
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- DXRX Stock
- Consensus Diaceutics PLC